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Abstract Motilin has never been isolated from rodents, the
most frequently used laboratory animals, despite several
attempts. We have isolated and sequenced the motilin precursor
from duodenal mucosa of guinea pig (GenBank accession number
AF323752) and studied its expression in several tissues. The
percent homology with human motilin is the lowest yet observed
due to several unique substitutions in the C-terminal end. As
expected, the precursor was present in the gut mucosa with the
exception of the gastric corpus. It was also present in medulla
oblongata, nucleus of the solitary tract, hypophysis, spinal cord,
hypothalamus, and cerebellum but not in the cerebral cortex. For
the first time we demonstrated motilin expression in the
thyroid. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Motilin is a 22 amino acid polypeptide, ¢rst puri¢ed and
sequenced from porcine duodenum [1]. Motilin stimulates gas-
trointestinal motor activity and, at least in man and in dog, it
seems to be involved in the regulation of the fasting motility
pattern [2]. In other species its role is less clear and has not
been studied in detail. In this respect it is striking that little
information is available on the e¡ects of motilin in commonly
used small laboratory animals such as rat, mouse and guinea
pig.
There are probably two reasons for this. Firstly, porcine
motilin has no or only weak e¡ects on gastrointestinal con-
tractility in these species [3]. Secondly, although motilin-like
immunoreactivity has been demonstrated in rat and guinea
pig brain [4], attempts to isolate the peptide [5] or to identify
its precursor [6] failed, suggesting the primary structure of
motilin in rodents was di¡erent. The two reasons may be
related, as only bioactivity may be species-speci¢c. For exam-
ple, canine but not porcine motilin has an e¡ect on strips from
canine small intestine [7].
We now report the ¢rst successful identi¢cation of a rodent
motilin.
2. Materials and methods
2.1. Oligonucleotides
All PCR primers and the hybridization probes were synthesized by
Gibco (New York, NY, USA). The oligo-dT16 anchor primer and the
PCR anchor primer were from the 3P/5P RACE (rapid ampli¢cation of
cDNA ends) kit (Boehringer Mannheim, Germany). Primers were
designed using the program PRIMER in the GCG program package
from BEN (Belgian European Molecular Biology Net node) and were
based on the known sequences of the precursor in other species. All
primers and probes used are listed in Table 1.
2.2. Total RNA extraction and cDNA synthesis
Total RNA was extracted from 1 g mucosa of the duodenum of the
guinea pig by the TRIzol Reagent method (Gibco, New York, NY,
USA). First strand cDNA was synthesized from 1 Wg total RNA using
200 units Superscript II RNase H3 Reverse Transcriptase (Gibco,
New York, NY, USA) and the oligo-dT16 anchor primer from the
RACE kit. The reaction mixture was ¢rst incubated at 42‡C for 1 h,
followed by incubation at 95‡C for 10 min.
2.3. PCR
2.3.1. PCR ampli¢cation of the middle portion of the motilin cDNA
sequence. The ¢rst strand cDNA pool of guinea pig intestine served
as a template for the PCR using 0.5 units of Thermus aquaticus (Taq)
DNA polymerase (Pharmacia Biotech, Uppsala, Sweden), the degen-
erate primer Gmot.for (0.5 WM) and the PCR anchor primer (0.5
WM). Ampli¢cation was performed at 94‡C (1 min), 53‡C (1 min),
72‡(1 min) for 38 cycles, followed by an extension step at 72‡C for
10 min. Further ampli¢cation was obtained in a semi-nested PCR
with degenerate primers Gmot.for and Gmot.rev. The PCR was an-
alyzed by electrophoresis on a 1.5% agarose gel and, after Southern
blot on a Biodyne0 A membrane (Gibco, New York, NY, USA),
hybridized with a 32P-labeled rabbit motilin cDNA probe (fragment
69^363 of rabbit motilin cDNA X63860). The rabbit cDNA fragment
was labeled using the Rediprime probe kit (Amersham Life Sciences,
Buckinghamshire, UK) and [K-32P]dCTP (ICN, Costa Mesa, CA,
USA).
2.3.2. Ampli¢cation of the 3P and 5P cDNA ends. This was done
with the 3P/5P RACE kit (Boehringer Mannheim, Germany), using
primers based upon the known sequence of the middle portion. The
RACE approach takes advantage of the poly-A tail at the 3P end of
mRNA to prepare cDNA extended with an anchor sequence. A spe-
ci¢c primer (Gp1.for) for the known middle portion and a primer
corresponding to the anchor sequence were then used to amplify a
terminal segment containing the unknown sequence. For the 5P end,
cDNA is extended with a poly-A tail to allow the same strategy to be
used. Here cDNA was synthesized from total RNA using the gene-
speci¢c primer GpSP1.rev and 30 units of the thermostable DNA
polymerase from Carboxydothermus hydrogenoformans (Roche,
Mannheim, Germany) (65‡C for 30 min). The single strand cDNA
(ss-cDNA) was puri¢ed by the High Pure PCR Product Puri¢cation
kit (Boehringer Mannheim, Germany). A homopolymeric A-tail was
added to the 5P end of the ss-cDNA by terminal transcriptase (Boehr-
inger Mannheim, Germany). Tailed ss-cDNA was ampli¢ed using the
gene-speci¢c primer GpSP2.rev and the oligo-dT16 anchor primer
from the kit, followed by a semi-nested PCR using the gene-speci¢c
reverse primer GpSP3.rev and the PCR anchor primer.
Analysis of PCR products was performed as described above except
that the probes used for hybridization were GpSP4.rev for the 5P
cDNA end and Gp2.for for the 3P cDNA end. The oligonucleotide
probes were labeled using [Q-32P]ATP (ICN, Costa Mesa, CA, USA)
and T4 polynucleotide kinase (Eurogentec, Belgium) followed by pu-
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ri¢cation on a NucTrap probe puri¢cation column (Stratagene, La
Jolla, CA, USA). The obtained 5P or 3P RACE products were cloned
as described in Section 2.4.
2.4. Cloning and sequencing of cDNA
PCR products that hybridized with the selected probe were ligated
into the pCR1 2.1 plasmid vector and transformed into E. coli InvK
competent cells (TA cloning kit, Invitrogen, San Diego, CA, USA).
After growing on LB plates containing 50 Wg/ml ampicillin, the clones
were grown separately in LB liquid medium containing ampicillin in
96 well plates and transferred to a Biodyne0 A membrane. Screening
of positive clones was performed by hybridization with the same 32P-
labeled oligonucleotide probe or the 32P-cDNA fragment used for the
analysis of the PCR products. The plasmid DNAs from positive
clones were extracted and puri¢ed by the Mini Qiagen Plasmid kit
manual (Qiagen, CA, USA). Sequencing was performed by an
AB1377 automatic £uorescent sequencer based on the dideoxy chain
termination method (Eurogentec, Belgium).
2.5. Distribution of the motilin precursor in guinea pig
Total RNA was extracted by the TRIzol reagent procedure (Gibco,
New York, NY, USA) from several tissues. Preparation of cDNA and
semi-nested ampli¢cation was performed as described in Section 2.3.1,
except that the primers Gp.for and Gp.rev were used (Table 1). PCR
products were analyzed on a 1.5% agarose gel. Southern blot hybrid-
ization was performed using a 32P-guinea pig motilin oligonucleotide
probe (GpSP1.rev).
3. Results and discussion
3.1. Isolation and sequencing of cDNA encoding the guinea pig
motilin precursor
Semi-nested PCR of cDNA prepared from total RNA iso-
lated from the duodenal mucosa of the guinea pig with the
degenerate primers (Gmot.for, Gmot.rev) and the PCR an-
chor primer resulted in four cDNA products (V180 bp,
V220 bp, V310 bp, V430 bp). Southern blot hybridization
analysis revealed that only the V220 bp product hybridized
with the 32P-rabbit cDNA probe. This band also had the
expected size (222 bp). PCR products were subcloned and
positive clones were sequenced. The length of the cloned
cDNA fragment was 222 bp and its sequence was used to
design primers for the ampli¢cation of the 3P and 5P cDNA
ends. Cloning and sequencing of the ampli¢ed 3P and 5P
cDNA ends revealed sequences of 367 and 154 bp.
Many problems were encountered in obtaining the 5P
cDNA end. Positive PCR products were only obtained if
the reverse transcription reaction was performed with the
thermostable DNA polymerase from C. hydrogenoformans
which can be used at a high temperature (65‡C). This may
indicate that a secondary structure in a GC-rich region of the
Table 1
Primers used to amplify the motilin precursor
Identi¢cation Sequence Positiona
Gmot.for 5P-GAAGSCTTYGTNCCNATHTTYAC-3P 83
Gmot.rev 5P-GTACTTTTCCAGCTGYCT-3P 304
GpSP1.rev 5P-CTGCTGCCTTTGACCTCTGC-3P 194
GpSP2.rev 5P-CTGTACGCTCAGGGACTTCCT-3P 175
GpSP3.rev 5P-TAGCCTTTTGTTCTGCTCCCT-3P 154
GpSP4.rev (probe) 5P-GTGTCCTCCGCAGCTCGCTG-3P 128
Gp1.for 5P-ACACAGGAAAGGGAGCAGAAC-3P 125
Gp2.for (probe) 5P-AGGCAGCAGGGCGGCTGGAGCCCC-3P 186
Gp.for 5P-TTCCAATCTTCACTTACAGCGAG-3P 93
Gp.rev 5P-CAATTTCCACTGGAGCAGTC-3 269
PCR anchor primer 5P-GACCACGCGTATCGATGTCGAC-3P
Oligo-dT16 anchor primer 5P-GACCACGCGTATCGATGTCGAC(T)16-3P
N = A+C+T+G; Y = C+T; S = C+G; H = A+T+C.
aNumbers indicate the 5P base of each primer. The numbering refers to the guinea pig precursor.
Fig. 1. Alignment of the amino acid sequences of the motilin precursor from di¡erent species. The most conserved region between species is in-
dicated with a dark background. Amino acids are numbered relative to the motilin peptide.
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5P cDNA end uncouples the reverse transcriptase. Subsequent
sequence analysis indeed con¢rmed that the signal peptide has
a high GC content (68%).
The cDNA sequences were con¢rmed by 15 independent
sequences obtained from nine di¡erent PCR products from
cDNA prepared from six guinea pigs. All gave identical re-
sults. The complete nucleotide sequence of the cDNA can be
consulted in the GenBank database, accession number
AF323752.
Analysis of the cDNA sequence of 491 bp revealed an open
reading frame of 381 bp initiated at the 5P end by AUG. The
stop codon TGA is located 378 bp downstream of the start
codon and is followed by a 3P untranslated region of 94 bp.
The polyadenylation signal sequence AATAAA is located 15
bp before the poly-A tail. The amino acid sequence deduced
from the cDNA sequence indicates that the guinea pig motilin
precursor consists of 127 amino acids. As in the other motilin
precursors, the sequence starts with a 25 amino acid signal
peptide followed by the 22 residues of the bioactive peptide
and an 80 amino acid ‘motilin-associated peptide’ (MAP)
(Fig. 1).
3.2. Homology with the motilin precursors from other species
cDNA encoding the motilin precursor has previously been
isolated and sequenced from man [8,9], pig [10], rabbit [11],
sheep [12], monkey [13], dog, chicken, horse, and cow [6]. In
every species the precursor consists of a 25 amino acid signal
peptide, 22 amino acid motilin itself and a MAP of variable
length. It is clear from Fig. 1 that the guinea pig precursor has
a similar structure.
To evaluate the similarity quantitatively, the percent homol-
ogy with the other precursors was calculated for the three
main regions of the precursor using the Wisconsin Genetics
Computer Group (GCG) package made available through the
Belgian European Molecular Biology Net Node (BEN). The
results are summarized in Table 2. While the homology is
rather high, as expected, it is of interest to note that for the
motilin peptide itself the values, ranging between 50 and 73%
for the amino acids and 67 and 79% for the nucleotides, are
low when compared with those obtained between the other
precursors. Indeed the lowest amino acid homology yet ob-
tained was 64%, and the average homology was 80%.
The reason for this are the large number of substitutions,
seven compared to human motilin, with four unique for the
guinea pig (Thr13, Gln18, Arg21, and Leu22) and one only
shared with the cow (Arg11) and rabbit (Arg16). Structure^
activity studies in the rabbit have shown that bioactivity is
mostly determined by the N-terminal end, especially residues
1, 4, and 7 [14,15], and it is assumed that the C-terminal
region (amino acids 10^22) forms an K-helix which stabilizes
the interaction of the N-terminal residues at the active site
[16]. It remains to be determined how these changes a¡ect
bioactivity.
The MAP starts with a putative endoproteinase dibasic
cleavage site, Arg23-Lys24. In all other precursors this is
Lys23-Lys24 but this change will not a¡ect the endoprotease
activity.
The function of the MAP region is unknown. It contains a
PEST region rich in proline (P), glutamate (E), serine (S), and
threonine (T), which may be subject to rapid intracellular
degradation and which extends from residues 54 to 68 in
the guinea pig. It also contains a highly conserved region at
Table 2
Homology of the guinea pig motilin precursor
Signal peptide Motilin MAP
aa nt aa nt aa nt
Man 84 85 68 74 57 74
Monkey 80 85 64 74 59 76
Pig 68 84 68 77 51 68
Sheep 80 87 59 74 57 74
Dog 84 90 59 76 57 74
Horse 76 88 68 77 59 73
Cow 76 85 64 77 59 75
Rabbit 92 96 73 79 55 68
Chicken 56 65 50 67 41 54
Fig. 2. Demonstration of the presence of motilin mRNA by RT-PCR in di¡erent tissues. Top: Agarose gel electrophoresis of ampli¢ed cDNA
of guinea pig corpus, gastric antrum, duodenum, jejunum, ileum, caecum, colon, gall bladder, pancreas, liver, thyroid, adrenal gland, urinary
bladder, uterus, cerebral cortex, hippocampus, hypothalamus, hypophysis, mesencephalon, pons, medulla oblongata, nucleus of the solitary
tract, spinal cord, and cerebellum. Motilin products correspond to the 177 bp band. Bottom: Hybridization of the agarose gel with the 32P-mo-
tilin oligonucleotide probe (GpSP1.rev). In all preparations only the 177 bp band hybridized.
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residues 67^73, although in the guinea pig residue 73 is histi-
dine instead of tyrosine.
An earlier analysis revealed that the homology of the signal
peptide and motilin was higher than in the MAP and con-
cluded that the MAP region probably evolved at a di¡erent
rate [6]. However, as can be seen from Table 2, the situation
in the guinea pig is di¡erent because the homology is highest
in the signal peptide and comparable but lower in motilin and
MAP. The signi¢cance of this ¢nding, which suggests that
motilin and MAP had the same evolutionary rate in this spe-
cies, remains to be determined.
3.3. Motilin mRNA expression in guinea pig
Expression of mRNA was found in several tissues as illus-
trated in Fig. 2. For all tissues tested PCRs were performed
with mRNA extracted from three animals, on three separate
occasions. In every experiment expression was found in the
same tissues. For the expression in the colon, thyroid, gall
bladder, hypothalamus, nucleus of the solitary tract, medulla
oblongata, and spinal cord, where the presence of motilin is
controversial or had not been reported until now, the result
was con¢rmed in a fourth animal. All cDNA samples were
tested in two independent PCRs.
As can be seen in Fig. 2, motilin mRNA was detected in the
duodenum. It should be noted that in pig, dog, man, cat, and
rabbit the duodenum is the richest source of motilin, and
motilin content decreases distally along the gastrointestinal
tract. Although our analysis is not quantitative, the bands
decrease in intensity for the more distal parts but surprisingly,
a very strong band was obtained in the colon. On the other
hand, the gastric corpus did not contain motilin mRNA, as is
the case in other species. We also found motilin expression in
gall bladder and urinary bladder mucosa, where it has never
yet been reported.
The presence of motilin in the central nervous system has
been debated for a long time. However, recently the issue has
been resolved by the demonstration of motilin mRNA in the
rabbit [17] and in the human brain [17]. We also detected
motilin expression in the medulla oblongata, nucleus of the
solitary tract, hypophysis, spinal cord, hypothalamus, and
cerebellum. In rabbit, the motilin receptor has also been de-
scribed in the hypothalamus and cerebellum [18], and this
suggests that motilin may play a central role. Recent studies
indeed indicate that the central administration of motilin ac-
tivates neural pathways in the brain [19]. Finally, it may be
noted that we detected motilin mRNA in the thyroid. Motilin
expression has never been studied in the thyroid, but we in-
cluded it in our exploration because the motilin receptor
which was recently cloned [20] also originated from the thy-
roid. It cannot be excluded that motilin may have some role in
regulating thyroid function.
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